Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394
Authors
Keywords
-
Journal
ONCOGENE
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-21
DOI
10.1038/s41388-023-02863-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The landscape of driver mutations in cutaneous squamous cell carcinoma
- (2021) Darwin Chang et al. npj Genomic Medicine
- Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
- (2021) Stephan Niland et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma
- (2021) Kristina Viiklepp et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- MISpheroID: a knowledgebase and transparency tool for minimum information in spheroid identity
- (2021) Arne Peirsman et al. NATURE METHODS
- Laser capture microdissection coupled mass spectrometry (LCM-MS) for spatially resolved analysis of formalin-fixed and stained human lung tissues
- (2020) Jeremy A. Herrera et al. Clinical Proteomics
- Matrix metalloproteinases in keratinocyte carcinomas
- (2020) Pilvi Riihilä et al. EXPERIMENTAL DERMATOLOGY
- H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma
- (2019) Elina Siljamäki et al. MATRIX BIOLOGY
- p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling
- (2019) Minna Piipponen et al. AMERICAN JOURNAL OF PATHOLOGY
- APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa
- (2018) Raymond J. Cho et al. Science Translational Medicine
- The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature
- (2018) Gareth J. Inman et al. Nature Communications
- RAF inhibitor PLX8394 selectively disrupts BRAF dimers and RAS-independent BRAF-mutant-driven signaling
- (2018) Zhan Yao et al. NATURE MEDICINE
- The PRIDE database and related tools and resources in 2019: improving support for quantification data
- (2018) Yasset Perez-Riverol et al. NUCLEIC ACIDS RESEARCH
- Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo
- (2017) Edward J. Hartsough et al. MOLECULAR CANCER THERAPEUTICS
- Significant Role of Collagen XVII And Integrin β4 in Migration and Invasion of The Less Aggressive Squamous Cell Carcinoma Cells
- (2017) Jyri M. Moilanen et al. Scientific Reports
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease
- (2016) Kyle A. Burton et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Dasatinib promotes apoptosis of cutaneous squamous carcinoma cells by regulating activation of ERK1/2
- (2016) Mehdi Farshchian et al. EXPERIMENTAL DERMATOLOGY
- The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
- (2016) Alex Kim et al. Expert Opinion on Drug Discovery
- Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinaseBRAF-mutant lung cancer
- (2016) Ross A. Okimoto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGF-β Signaling from Receptors to Smads
- (2016) Akiko Hata et al. Cold Spring Harbor Perspectives in Biology
- Non-Smad Signaling Pathways of the TGF-β Family
- (2016) Ying E. Zhang Cold Spring Harbor Perspectives in Biology
- Regulation of TGF-β Family Signaling by Inhibitory Smads
- (2016) Keiji Miyazawa et al. Cold Spring Harbor Perspectives in Biology
- Paradoxical activation of MEK/ERK signaling induced by B-Raf inhibition enhances DR5 expression and DR5 activation-induced apoptosis in Ras-mutant cancer cells
- (2016) You-Take Oh et al. Scientific Reports
- Complement Factor I Promotes Progression of Cutaneous Squamous Cell Carcinoma
- (2015) Pilvi Riihilä et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- RAF inhibitors that evade paradoxical MAPK pathway activation
- (2015) Chao Zhang et al. NATURE
- Matrix metalloproteinases in inflammation
- (2014) Liisa Nissinen et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- NOTCH1 Mutations Occur Early during Cutaneous Squamous Cell Carcinogenesis
- (2014) Andrew P. South et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of mutant BRAF splice variant signaling by next-generation, selective RAF inhibitors
- (2014) Kevin J. Basile et al. Pigment Cell & Melanoma Research
- Complement Factor H: A Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
- (2013) Pilvi M. Riihilä et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effect of laminin 332 on motility and invasion in bladder cancer
- (2013) Sung-Gu Kang et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells
- (2013) Kaitlyn Le et al. Pigment Cell & Melanoma Research
- From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma
- (2012) Vladimir Ratushny et al. JOURNAL OF CLINICAL INVESTIGATION
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- RASMutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
- (2012) Fei Su et al. NEW ENGLAND JOURNAL OF MEDICINE
- Keratinocyte Growth Factor Induces Gene Expression Signature Associated with Suppression of Malignant Phenotype of Cutaneous Squamous Carcinoma Cells
- (2012) Mervi Toriseva et al. PLoS One
- Laminin-332-Rich Tumor Microenvironment for Tumor Invasion in the Interface Zone of Breast Cancer
- (2011) Baek Gil Kim et al. AMERICAN JOURNAL OF PATHOLOGY
- Serpin Peptidase Inhibitor Clade A Member 1 (SerpinA1) Is a Novel Biomarker for Progression of Cutaneous Squamous Cell Carcinoma
- (2011) Mehdi Farshchian et al. AMERICAN JOURNAL OF PATHOLOGY
- Switching TGFβ from a tumor suppressor to a tumor promoter
- (2011) Gareth J Inman CURRENT OPINION IN GENETICS & DEVELOPMENT
- RASMutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
- (2011) Patrick A. Oberholzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Transforming growth factor β1 enhances tumor promotion in mouse skin carcinogenesis
- (2010) Rolando Pérez-Lorenzo et al. CARCINOGENESIS
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Expression Profiles and Clinical Correlations of Degradome Components in the Tumor Microenvironment of Head and Neck Squamous Cell Carcinoma
- (2010) A. Stokes et al. CLINICAL CANCER RESEARCH
- RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
- (2010) Poulikos I. Poulikakos et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
- (2010) Ruth Halaban et al. Pigment Cell & Melanoma Research
- MMP-10 (Stromelysin-2) and MMP-21 in human and murine squamous cell cancer
- (2009) Sonja Boyd et al. EXPERIMENTAL DERMATOLOGY
- Defining the role of laminin-332 in carcinoma
- (2009) Cherise M. Guess et al. MATRIX BIOLOGY
- Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas
- (2008) A.K. Kivisaari et al. BRITISH JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search